TRACI GLANZ: Open Payments
NPI 1477066116 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 12 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $86 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Incyte Corporation | 2 | $40 |
| ABBVIE INC. | 2 | $33 |
| Lilly USA, LLC | 1 | $20 |
| Kite Pharma, Inc. | 1 | $20 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: KEYTRUDA, MONJUVI, FRUZAQLA, ICLUSIG, VERZENIO, Yescarta, IMBRUVICA, NERLYNX.
Industry payments across FL — which companies pay providers there.
